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Abstract 
 
Membrane proteins are targeted by over 50 % of marketed pharmaceuticals, and as most 
membrane proteins are not naturally abundant, they must be produced recombinantly for the 
structural biology that is a pre-requisite to structure-based drug design. Unfortunately, obtaining 
high yields of functional, recombinant membrane proteins remains a major bottleneck in 
contemporary bioscience. Trial-and-error optimisation studies have not (and cannot) reveal 
mechanistic details of the biology of recombinant protein production, highlighting the need for 
defined and rational optimisation strategies based upon experimental observation. To this end, we 
have published a transcriptome and subsequent genetic analysis that has identified genes 
implicated in high-yielding yeast cell factories. These results have highlighted a role for alterations 
to a cell’s protein synthetic capacity in the production of high yielding cells: paradoxically, reduced 
protein synthesis favors higher yields of recombinant membrane protein.  These results highlight a 
potential bottleneck at the protein folding or translocation stage of protein production.   
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1. Introduction 
Membrane proteins are the targets of well over 50 % of pharmaceuticals on the market. In all 
cases these drugs have been designed in the absence of specific structural knowledge of their 
target. For example, G protein-coupled receptors (GPCRs) are the largest human receptor family 
controlling a range of essential processes and yet the structures of just six of them are available, 
five having been published only in the last 3 years [1, 2]. In 1997, 23 pharmaceuticals were 
approved by the FDA, with just 17 approvals in 2007 [3]. Furthermore, 418 potential 
biopharmaceutical medicines were in development in 2006 but only 24 new medicines were 
approved in 2008. This slow down is due in part to the lack of new structural and functional 
information available for membrane proteins [4]. Since they are not naturally abundant, membrane 
proteins must be overproduced for the detailed studies that will validate them for entry into the drug 
discovery pipeline. Consequently obtaining high yields of functional, recombinant membrane 
protein remains a major research challenge [5, 6]. 
 
We and others have recognized that the root of the problem is the host organism, and the lack of 
knowledge about the intricate cellular biology within. In our own work on yeast, we previously 
identified 39 Saccharomyces cerevisiae genes whos  expression was significantly altered when 
the aquaporin, Fps1, was produced under high-yielding conditions (20°C, pH5) compared to low-
yielding standard growth conditions (30°C, pH5) [7]. In particular an essential gene, BMS1, with a 
role in ribosome biogenesis, was identified as always up-regulated in high-yielding host cells [8]. 
This approach stands out from the repeated rounds of trial-and-error “optimisation” typically 
adopted in the field [9] as well as targeted deletion approaches in protease or secretion pathways, 
based on speculation of where bottlenecks might be. Although these approaches could be 
successful on a case-by-case basis, they have not (and cannot) reveal the mechanisms at work in 
a high-yielding cell. In contrast, genetic methods have enabled the engineering of high-yielding 
yeast strains. 
 
The challenge now is to understand the underlying mechanisms, which will facilitate the reliable 
production of membrane proteins through an improved understanding of the yeast host cell. In the 
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long-term it will contribute directly to the drug discovery pipeline and hence benefit an ageing 
population who will increasingly require access to new drugs to combat diseases including 
diabetes, cancer, and neurological disorders, as well as providing solutions for developing nations 
against diseases such as malaria and viral infection.  
 
2. The biosynthesis of recombinant membrane proteins  
Our current understanding of how native membrane proteins are synthesized in the cell is 
incomplete (Fig. 1), with each host cell having an array of molecules involved in the biogenesis 
pathway [10, 11]. In principle any membrane protein could be produced recombinantly in any host 
cell system, but the yield is likely to be very low on account of these differences. Consequently, the 
preferred host cell is generally accepted to be that which is closest in origin to the source of the 
target membrane protein, which reflects the unknown requirements for a range of biosynthetic 
components. As this may not always be the most practical of solutions, especially for producing 
human membrane proteins, strategies are required that allow heterologous host cells to achieve 
the extended production profiles (often in excess of 2 hours) necessary for the biosynthesis of 
human membrane proteins [12, 13]. Successful approaches have therefore typically relied on using 
low copy number plasmids, weak promoters and low temperatures as this is thought to allow 
sufficient time for folding of the membrane protein, whilst keeping the amount of mRNA encoding 
the mammalian membrane protein, and hence the stress on the host cell, to a minimum. 
 
It is well known that membrane proteins can fold inefficiently. The cystic fibrosis transmembrane 
conductance regulator is a good example of this, as only 25-30 % of the nascent polypeptide chain 
makes it to the cell surface in a correctly-folded state, with the remainder being misfolded and 
degraded in the endoplasmic reticulum (ER). One strategy to improve the functional yield of 
membrane proteins has therefore been to co-express molecular chaperones that are known to 
facilitate folding. One of the first examples of this relatively unexplored approach was performed by 
Chris Tate in 1999 [14] and gave a 3-fold improvement in functional yield of the serotonin 
transporter (SERT) in the baculovirus system. However, co-expression of further molecular 
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5 
chaperones actually decreased SERT yields, suggesting that the biosynthetic bottleneck had now 
been shifted to another step.  
 
The more recent application of “omics” technologies has been driven by attempts to obtain a global 
understanding of recombinant membrane protein production in bacteria and yeast [8, 15] and to 
identify the mechanisms associated with high-yielding cells. In the prokaryote host, Escherichia 
coli, increases in levels of chaperones and proteases were found to be associated with increased 
membrane protein production [15], which concurred with the SERT experiments in the baculovirus 
system. The authors further speculated that low yields of recombinant membrane proteins might be 
due to limited Sec translocon capacity. A second prokaryote, the Gram-positive bacterium 
Lactococcus lactis, has also been used to produce a wide range of eukaryotic and prokaryotic 
membrane proteins [16], enabling a comparison of L. lactis and E. coli [17]. Although a large 
fraction of proteins could be produced in both hosts, some could only be produced in one or the 
other. Notably, for about half of the proteins produced in E. coli additional bands of lower molecular 
weight were observed, indicative of breakdown products, whereas only 10 % of the proteins 
produced in L. lactis were degraded. A genetic study of L. lactis, identified a series of mutations 
specific to the L. lactis system that did not overlap with the findings in E. coli: three mutant strains 
that displayed 2- to 8-fold improvements in the yields of several target proteins were shown to 
carry single-site mutations in the nisK gene. NisK is the sensor protein of a two-component 
regulatory system that directs nisin-A-mediated expression [18]. 
 
In our own study of the S. cerevisiae response to membrane protein production [7], genes that 
were down-regulated under low yielding conditions were up-regulated under high-yielding 
conditions and vice versa [8] (Table 1). This lent confidence to the fact that these genes might 
have a role in high-yielding protein production, which was subsequently further validated by strain 
engineering. Specifically, we used this approach to engineer the first yeast production strains 
(GB0813253.2) by rational design [19]. In particular, the spt3∆, srb5∆ and gcn5∆ mutant strains 
were effective production hosts not only for the glycerol channel, Fps1, where the yield 
improvement was 10- to 60-fold higher than a wild-type control, but also the human GPCR, 
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6 
adenosine 2a receptor (hA2aR), where we doubled the functional yield compared to wild-type [8]. 
Although the three deleted genes have previously been identified as components of transcriptional 
complexes [20], improved yields of Fps1 were not correlated with increased promoter activity or 
FPS1 transcript copy number in the deletion strains. An observed up-regulation of BMS1 of 6- to 7-
fold over wild-type in each of these three deletion strains, as determined by Q-PCR, suggested the 
importance of ribosome biogenesis in high-yielding membrane protein experiments. Subsequent 
overexpression of BMS1, where the endogenous promoter is replaced with a doxycycline-titratable 
promoter in the genome, revealed that maximal Fps1 yield was significantly correlated with an 
optimum level of BMS1 transcript, which was further correlated with a changed ribosomal subunit 
stoichiometry. This observation was also true at different doxycycline concentrations for hA2aR 
and soluble GFP [8].  
 
The knowledge generated by these and other studies should now provide an impetus to define the 
characteristics of high-yielding strains. Unsurprisingly, however, differences emerge between host 
cells. For example, our transcript analysis in yeast [7] identified up-regulation of SEC62 in high 
yielding protein production. Sec62 is an essential subunit of the Sec63 complex (Sec63, Sec62, 
Sec66 and Sec72) and with the Sec61 complex, Kar2 (the yeast binding immunoglubulin protein, 
BiP) and Lhs1 forms a channel competent for SRP-dependent and post-translational SRP-
independent protein targeting and import into the ER. We found a SEC63 over-expression strain 
did not give improved recombinant protein yields. Additionally, we found that SRP102, which 
encodes the signal recognition particle receptor β subunit, was down-regulated in high-yielding 
experiments and again that a srp102∆ strain gave only wild-type yields of membrane protein. 
Whilst this does not preclude the eukaryotic secretory pathway from having a limiting effect in S. 
cerevisiae translational efficiency, it does highlight clear differences between prokaryotic and 
eukaryotic cells. As discussed in the next section, some features of high-yielding cells are likely to 
be common to a range of host types, whilst many will no doubt turn out to be host- and/or target 
protein-specific. 
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7 
3. The characteristics of high-yielding yeast cells  
3.1 Slowed cell growth 
The slowing of growth that can accompany high-yielding protein production [8, 21] is often 
attributed to the metabolic burden associated with achieving these yields. Such observations are 
typical for cells which have improved “per cell” yields; more protein in the membrane of every cell 
equates to higher total yields. We have recently shown that such high-yielding yeast cells have a 
more efficient metabolism than low-yielding cells [8]. For S. cerevisiae, these high yielding 
conditions are associated with low fermentative activity [8]: 16 % less ethanol and 6.5 % less dry 
weight than wild-type under the same conditions and a lower average exponential phase RQ (RQ 
= 3.6) than wild-type (RQ = 4.1; in agreement with literature values for wild-type strains grown on 
glucose [22]). These observations are consistent with measurements of metabolic load in other 
recombinant host systems, albeit those producing heterologous soluble proteins: for example, 
Kemp and colleagues used on-line flow microcalorimetry data to examine metabolic load in 
mammalian cells [23], while thermal methods [24] and analysis of off-gases [21] were used to 
monitor E. coli cultures. 
 
The accumulation of host cell biomass might be expected to provide a complementary strategy to 
increase the total protein yield; more cells equates to more membranes and hence to more 
recombinant protein. For example, the widely-used E. coli “Walker strains” (C41 and C43) 
apparently result in higher yields of recombinant membrane protein because their growth is not 
strongly inhibited upon induction. This results in increased biomass rather than increased “per cell” 
yields [25]. In yeast, however, the specific activity of some GPCRs is often lower when high cell 
density cultures are induced [26]. Indeed, it has been noted that higher cell densities can generate 
cellular stresses leading to modifications in membrane composition [27] and that this modified 
environment influences the activity of recombinant proteins. Consequently, medium cell density 
fermentation procedures for GPCR production have been suggested to be preferable to ones 
where biomass yields are maximized [26]. In a recent example of host development, a purely 
respiratory S. cerevisiae strain was reported that has improved biomass properties, permitting 
increased volumetric yields without the need to resort to complex control or cultivation schemes. In 
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8 
the case of the human adenosine A2A receptor (A2AR), the functional yield obtained in wild-type 
cells was quadrupled when using this strain under the same experimental conditions [28, 29]. 
 
3.2 Reduced translational activity 
The finding that high-yielding yeast strains can have altered ribosomal subunit stoichiometry 
highlights the protein synthetic machinery and translational capacity of the cell as key determinants 
of improved recombinant membrane protein yield.  As ribosome biogenesis is a major consumer of 
cellular energy resources and its regulation is intimately linked to cell size, which in turn affects cell 
growth as well as influencing other features such as the way that cells respond to stress, these 
observations are further consistent with the slow growth phenotype of high-yielding cells discussed 
in the previous section.  
 
Previously, high yields of secreted recombinant protein have been obtained upon overexpression 
of RPP0, which encodes a ribosomal protein [30]. Furthermore, the production of heterologous 
membrane proteins has been shown to lead to the de-repression of GCN4 translation [31]. GCN4 
serves as an intracellular marker for the level of the eIF2-GTP-Met-tRNAi ternary complex, which is 
critical for highly active translation initiation [32]. Overall, these results suggest that production of 
heterologous membrane proteins represses global cap-dependent translation initiation. For specific 
mRNAs, such as GCN4, translation is activated under conditions where the global translation 
initiation is inhibited via upstream open reading frames [33]. Another mechanism allowing the 
expression of specific mRNAs under conditions of global translation repression has more recently 
been described where the presence of adenosine-rich sequences upstream of the start codon 
leads to translation initiation via a cap-independent mechanism [34]. Intriguingly, the insertion of 
adenosine residues upstream of the start codon has also been identified as stimulating increased 
yields of heterologous proteins [35].  Thus, in attempting to rationally optimize heterologous 
membrane protein production, careful assessment of the rate and mechanism of synthesis of the 
heterologous protein relative to endogenous protein may prove critical.  
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9 
3.2 An up-regulated unfolded protein response 
A key consideration when optimizing the production of recombinant proteins via the secretory 
pathway is the physiological responses that have evolved to maximize protein folding in the ER.  
The unfolded protein response (UPR) senses increases in unfolded protein within the ER and 
transmits this signal to pathways that increase the level of ER chaperones to maximize cellular 
output (Fig. 2).  Indeed, yeast cells producing a GPCR were found to exhibit the hallmarks of a 
constitutively-active UPR [36]. In mammalian cells, activation of UPR-like responses has been 
shown to significantly improve recombinant protein production [37-39]. Similarly, in yeast over-
expression of the genes encoding the Kar2 and PDI chaperones both reduced the UPR and 
increased heterologous protein production [40].   
 
The UPR pathway is significantly simpler in yeast than in higher eukaryotes as only a single 
transmembrane protein kinase/nuclease, Ire1, is involved (Fig. 2). In current models, the 
accumulation of unfolded protein sequest rs the Kar2 chaperone away from Ire1 causing it to 
dimerize and autophosphorylate. This activates the nuclease activity of Ire1 towards its 
cytoplasmic substrate Hac1 thereby inducing an unusual splicing event. This in turn leads to 
translation of the Hac1 transcription factor allowing the induction of several hundred genes, 
including ER-resident chaperones [41]. Clearly, as well as improving the yield of recombinant 
membrane proteins, many of the factors highlighted above, such as reduced protein synthesis, 
slower growth rate and lower cell densities, will also influence the level of UPR in cells. The UPR 
has therefore been identified as a target for improvements in heterologous protein yield in different 
yeast species [27], including S. cerevisiae [42], in order to produce recombinant membrane 
proteins. In the latter study, the UPR was exploited to optimize synthesis rates of membrane 
proteins in order to most efficiently use the cell’s biosynthetic machinery. The authors noted, 
however, that some membrane proteins (especially those from yeast or plants) had little effect on 
the activity of the UPR, meaning that this may not be a globally applicable approach. 
Overexpression of P. pastoris HAC1 was subsequently used to increase the production of some 
heterologous proteins in P. pastoris, including the doubling of functional yields of a GPCR [43]. 
Overall, it is intriguing that in contrast to the mammalian UPR, the simpler UPR of yeast does not 
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10 
involve the down-regulation of translation to reduce the protein synthetic load on the ER [44].  It is 
therefore possible that a reduced protein synthetic capacity in yeast has proved particularly 
effective in improving recombinant protein yields since it targets an area that is unregulated in 
response to unfolded protein in cells.   
 
3.1 Up-regulation of BMS1 
Bms1, an essential nucleolar protein that is conserved throughout the eukaryotic kingdom, has a 
regulatory role in the biogenesis of the 40S subunit [45] as well as being a GTP-binding protein 
[46]. We have shown that recombinant protein translation is clearly enhanced by the 
overexpression of BMS1 and that at maximal Fps1 yield there are elevated levels of both 40S and 
60S subunits (Fig. 3) without any significant decrease in the levels of 80S or polysome [8]. When 
the ribosome subunits were dissociated in the presence of EDTA, the ratio of 60S to 40S subunits 
was 2:1 under the highest yielding conditions [8], but the relationship between this altered 
stoichiometry and improved recombinant protein yield remains unclear. Nonetheless, we are 
unaware of any other single effector that exerts such a huge effect in yeast or any other host cell. 
 
Ribosomes catalyze protein synthesis in all cells, but in eukaryotic cells >170 proteins and >70 
RNAs are involved in a complex and highly regulated process. Bms1 has been proposed to 
interact with Rcl1 in a GTP-dependent manner, shuttling Rcl1 to pre-ribosomes via its affinity for 
U3 snoRNA [47]. We find that overexpression of RCL1 does not correlate with improved protein 
yields, but this may be due to Bms1 being limiting. Using a more severe FAL1 mutant strain [48], 
which has a massively increased 60S:40S ratio due to a severe reduction in 40S subunit 
biogenesis, we observe no improvement in recombinant protein yield. Therefore the more subtle 
alterations in ribosomal stoichiometry of the BMS1 overexpression strain appear critical for high 
recombinant protein yields. We previously noted that mice that lacked 40S synthesis, but had 
normal 60S synthesis in the liver, survived for several weeks. Their livers responded to fasting and 
re-feeding cycles, in which the mass of the liver nearly doubles. However, partial hepatectomy in 
normal animals led to rapid re-growth and cell division, but the livers of mice defective in the 
production of 40S ribosomal subunits did not re-grow and showed no signs of cell division [49]. 
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11 
These results suggest that a lack of 40S ribosome biogenesis can induce a checkpoint control that 
prevents cell cycle progression. This is consistent with our observed slowing of growth that 
accompanies high-yielding protein production. 
 
4. Concluding remarks  
We have shown that comparative transcriptome analysis of S. cerevisiae host cells during high- 
versus low-yielding recombinant protein production experiments can guide strain engineering. In 
particular, by titrating the overexpression of BMS1, a ribosome biogenesis gene, the functional 
yields of a range of membrane proteins can be improved. With the recent publication of a curated 
P. pastoris genome [50] it will now be possible to transfer this technology to a second industrially-
relevant yeast species and we further predict that this approach will be used for a range of host 
cells and protein targets [51]. As array techniques have improved, it is now possible to relate 
changes in mRNA with changes at the protein level. A comparative proteome analysis of 
membrane versus soluble protein production in E. coli highlighted that the cytoplasmic membrane 
protein translocation machinery might be limiting in low-yielding bacterial transformants [15]. 
Interestingly, we found no evidence for this in yeast [8], which highlights clear differences between 
prokaryotic and eukaryotic cells. With time, the ability to combine the outputs from these types of 
studies with those from metabolomic approaches will contribute to a true systems biotechnological 
description of recombinant membrane protein production in yeast. 
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Table 
 
 
Table 1 Array data from a transcriptome analysis of yeast strains giving high or low yields 
of recombinant membrane protein: results for verified genes Genes were tabulated if their 
expression was changed when comparing both of the low yielding conditions (I and II) with normal 
growth conditions: 30 °C (pH 5) to 35 °C (pH 7) and 30 °C (pH 5) to 35 °C (pH 5). The change is 
expressed as a factor (in parentheses), where that factor is x when a gene expressed with intensity 
1 at 30 °C pH 5 is expressed with intensity x at the new condition. Arrows show whether the gene 
is up- or down-regulated. The results for the high-yielding conditions are shown for comparison. 
Only the data for ERG9 deviate from the pattern that genes that are down-regulated under low 
yielding conditions are up-regulated under high-yielding conditions and vice versa [52]. 
 
 
Systematic 
name 
Gene 30 ºC pH5 
to 
35 ºC pH7 
(low yield I) 
30 ºC pH5 
to 
35 ºC pH5 
(low yield II) 
30 ºC pH5 
to 
20 ºC pH5 
(high yield) 
 
YPL217C BMS1 ⇓ (0.2) ⇓ (0.2) ⇑ (2.0) 
YGR286C BIO2 ⇑ (5.3) ⇑ (5.5) ⇓ (0.4) 
YPR019W CDC54 ⇓ (0.2) ⇓ (0.2) ⇑ (2.6) 
YPL254W HFI1 ⇓ (0.2) ⇓ (0.1) ⇑ (2.2) 
YBR296C PHO89 ⇓ (0.1) ⇓ (0.04) ⇑ (3.7) 
YBR253W SRB6 ⇓ (0.3) ⇓ (0.3) ⇑ (1.4) 
YBR288C APM3 ⇓ (0.2) ⇓ (0.3) ⇑ (1.7) 
YGL029W CGR1 ⇓ (0.2) ⇓ (0.3) ⇑ (1.7) 
YOR303W CPA1 ⇓ (0.3) ⇓ (0.3) ⇑ (1.6) 
YHR190W ERG9 ⇑ (3.3) ⇑ (3.0) ⇑ (2.4) 
YPL187W mf(alpha)1 ⇑ (3.9) ⇑ (3.7) ⇓ (0.6) 
YPL104W MSD1 ⇓ (0.3) ⇓ (0.3) ⇑ (1.5) 
YPL206C PGC1 ⇓ (0.4) ⇓ (0.4) ⇑ (1.4) 
YFL036W RPO41 ⇓ (0.3) ⇓ (0.3) ⇑ (2.6) 
YPL094C SEC62 ⇓ (0.3) ⇓ (0.2) ⇑ (1.5) 
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Figure legends 
 
 
Figure 1 Strategies to overcome bottlenecks in the production of recombinant membrane 
proteins.  The scheme shows the pathway of membrane protein production in yeast cells. Various 
steps are depicted including mRNA transcription and processing in the nucleus, mRNA export into 
the cytoplasm through the nuclear pore, the synthesis of protein from mRNA, the translocation and 
insertion of protein into the endoplasmic reticulum (ER) membrane and the folding and 
glycosylation of membrane proteins through the secretory pathway. Strategies used to optimize 
recombinant membrane protein production are highlighted. 
 
Figure 2 The yeast unfolded protein response (UPR). The scheme shows the consequences of 
unfolded protein accumulation in the endoplasmic reticulum (ER) lumen and the pathway that is 
consequently activated. Steps depicted include the dissociation of Kar2 from the Ire1 
transmembrane kinase/endonuclease, the dimerisation and phosphorylation of Ire1, the unusual 
mechanism of HAC1 mRNA splicing and the role of Hac1 protein in the transcriptional activation of 
genes which increase the capacity of the ER. 
 
Figure 3 Polysome profiles for the BMS1 and wild-type strains (A) Polysome OD254 profiles for 
yeast strains producing Fps1 in the absence (upper panels) or presence (lower panels) of 0.5 
µg/mL doxycycline. Addition of 0.5 µg/mL doxycycline to the BMS1 mutant strain leads to 
maximum yields of Fps1 (70 times higher than wild-type) compared to low yields under all other 
conditions shown. Polysome peaks containing 2, 3 and 4 ribosomes are visible. (B) Ribosome 
disassociation profiles at OD254 for 50 mM EDTA-treated samples of wild-type and BMS1 strains 
producing Fps1 in the absence and presence of 0.5 µg/mL doxycycline (upper and lower panels 
respectively). Changes in peak heights and ratios of 60S and 40S subunits for all four conditions 
are tabulated. Reproduced from reference [8]. 
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Change in peak heights (%) between culture conditions 40S 60S Change in 
60S:40S  
WT to WT + doxycycline -13.5 -8.3 No change 
WT to yTHCBMS1 +17.3 +33.3 No change 
WT to yTHCBMS1 + doxycycline -32.7 +16.7 1.2 to 2.0 
yTHCBMS1 to yTHCBMS1 + doxycycline -42.6 -12.5 1.3 to 2.0 
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